These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33952261)

  • 1. Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis.
    Karampitsakos T; Torrisi S; Antoniou K; Manali E; Korbila I; Papaioannou O; Sampsonas F; Katsaras M; Vasarmidi E; Papakosta D; Domvri K; Fouka E; Organtzis I; Daniil Z; Dimeas I; Kirgou P; Gourgoulianis KI; Papanikolaou IC; Markopoulou K; Kounti G; Tsapakidou E; Papadopoulou E; Tatsis K; Gogali A; Kostikas K; Tzilas V; Chrysikos S; Papiris S; Bouros D; Kreuter M; Tzouvelekis A
    Respir Res; 2021 May; 22(1):140. PubMed ID: 33952261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Red Cell Distribution Width in Idiopathic Pulmonary Fibrosis and Combined Pulmonary Fibrosis Emphysema.
    Gürün Kaya A; Özyürek BA; Şahin Özdemirel T; Öz M; Erdoğan Y
    Med Princ Pract; 2021; 30(2):154-159. PubMed ID: 32841950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study.
    Scott MKD; Quinn K; Li Q; Carroll R; Warsinske H; Vallania F; Chen S; Carns MA; Aren K; Sun J; Koloms K; Lee J; Baral J; Kropski J; Zhao H; Herzog E; Martinez FJ; Moore BB; Hinchcliff M; Denny J; Kaminski N; Herazo-Maya JD; Shah NH; Khatri P
    Lancet Respir Med; 2019 Jun; 7(6):497-508. PubMed ID: 30935881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium-long term prognosis prediction for idiopathic pulmonary fibrosis patients based on quantitative analysis of fibrotic lung volume.
    Du K; Zhu Y; Mao R; Qu Y; Cui B; Ma Y; Zhang X; Chen Z
    Respir Res; 2022 Dec; 23(1):372. PubMed ID: 36550474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis.
    Kreuter M; Lee JS; Tzouvelekis A; Oldham JM; Molyneaux PL; Weycker D; Atwood M; Kirchgaessler KU; Maher TM
    Am J Respir Crit Care Med; 2021 Jul; 204(1):74-81. PubMed ID: 33434107
    [No Abstract]   [Full Text] [Related]  

  • 6. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
    Tzouvelekis A; Herazo-Maya JD; Slade M; Chu JH; Deiuliis G; Ryu C; Li Q; Sakamoto K; Ibarra G; Pan H; Gulati M; Antin-Ozerkis D; Herzog EL; Kaminski N
    Respirology; 2017 Apr; 22(3):486-493. PubMed ID: 27761978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
    Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
    [No Abstract]   [Full Text] [Related]  

  • 8. The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosis.
    Nathan SD; Reffett T; Brown AW; Fischer CP; Shlobin OA; Ahmad S; Weir N; Sheridan MJ
    Chest; 2013 Jun; 143(6):1692-1698. PubMed ID: 23238641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis.
    Akagi T; Matsumoto T; Harada T; Tanaka M; Kuraki T; Fujita M; Watanabe K
    Respir Med; 2009 Aug; 103(8):1209-15. PubMed ID: 19251407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a nomogram for predicting the presence of combined pulmonary fibrosis and emphysema.
    Yuan X; Jin J; Xu X
    BMC Pulm Med; 2021 Nov; 21(1):349. PubMed ID: 34743726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical relevance of lymphocyte to monocyte ratio in patients with Idiopathic Pulmonary Fibrosis (IPF).
    Bernardinello N; Grisostomi G; Cocconcelli E; Castelli G; Petrarulo S; Biondini D; Saetta M; Spagnolo P; Balestro E
    Respir Med; 2022 Jan; 191():106686. PubMed ID: 34847517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
    Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
    Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of clinical features between patients with idiopathic pulmonary fibrosis combined with emphysema and without emphysema].
    Ma JW; Li ZH; Xu H; Wang HJ; Kang J; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):173-6. PubMed ID: 23856138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial 6-month change in forced vital capacity predicts subsequent decline and mortality in Japanese patients with newly diagnosed idiopathic pulmonary fibrosis.
    Toi Y; Takei R; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Fukuoka J; Johkoh T; Kondoh Y
    Respir Investig; 2021 May; 59(3):335-341. PubMed ID: 33551330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis.
    Bahmer T; Kirsten AM; Waschki B; Rabe KF; Magnussen H; Kirsten D; Gramm M; Hummler S; Brunnemer E; Kreuter M; Watz H
    BMC Pulm Med; 2017 Jul; 17(1):104. PubMed ID: 28743305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].
    Li ZH; Peng SC; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multidimensional index and staging system for idiopathic pulmonary fibrosis.
    Ley B; Ryerson CJ; Vittinghoff E; Ryu JH; Tomassetti S; Lee JS; Poletti V; Buccioli M; Elicker BM; Jones KD; King TE; Collard HR
    Ann Intern Med; 2012 May; 156(10):684-91. PubMed ID: 22586007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictors of mortality in IPF - Does emphysema change the prognosis?
    Tokgoz Akyıl F; Sevim T; Akman C; Aksoy E; Ağca M; Aktas O; Akyıl M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):267-274. PubMed ID: 27758993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.